BG105011A - Composition containing paroxetine - Google Patents

Composition containing paroxetine

Info

Publication number: BG105011A
Authority: BG; Bulgaria
Prior art keywords: composition containing; containing paroxetine; hemihydrate; paroxetine; formulated
Prior art date: 1998-05-13

Application number

BG105011A

Other languages

Bulgarian (bg)

English (en)

Inventor

David Elder

Graham LEONARD

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-13

Filing date

2000-11-30

Publication date

2001-07-31

2000-11-30 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-07-31 Publication of BG105011A publication Critical patent/BG105011A/xx

Links

AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 3
AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1
239000002775 capsule Substances 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229960005183 paroxetine hydrochloride Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

BG105011A 1998-05-13 2000-11-30 Composition containing paroxetine BG105011A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9810180.1A GB9810180D0 (en)	1998-05-13	1998-05-13	Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en)	1998-05-13	1999-05-13	Novel formulation containing paroxetine

Publications (1)

Publication Number	Publication Date
BG105011A true BG105011A (en)	2001-07-31

Family

ID=10831926

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG105011A BG105011A (en)	1998-05-13	2000-11-30	Composition containing paroxetine

Country Status (20)

Country	Link
EP (1)	EP1077685A2 (id)
JP (1)	JP2002514593A (id)
KR (1)	KR20010043545A (id)
CN (1)	CN1309557A (id)
AP (1)	AP2000001985A0 (id)
AU (1)	AU3941099A (id)
BG (1)	BG105011A (id)
BR (1)	BR9910402A (id)
CA (1)	CA2331849A1 (id)
EA (1)	EA200001173A1 (id)
GB (1)	GB9810180D0 (id)
HU (1)	HUP0101931A3 (id)
ID (1)	ID27018A (id)
IL (1)	IL139596A0 (id)
NO (1)	NO20005681L (id)
PL (1)	PL344872A1 (id)
SK (1)	SK16972000A3 (id)
TR (1)	TR200003351T2 (id)
WO (1)	WO1999058116A2 (id)
ZA (1)	ZA200006465B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4854115B2 (ja) *	1999-03-12	2012-01-18	エイシカファーマシューティカルスリミテッド	無水パロキセチン用安定製剤形
HU226912B1 (en) *	2000-04-07	2010-03-01	Richter Gedeon Nyrt	New paroxetin salt and medicament containing it
JP6062422B2 (ja) *	2012-03-29	2017-01-18	杏林製薬株式会社	カプセル製剤
DE102013207447A1 (de)	2013-04-24	2014-10-30	Evonik Degussa Gmbh	Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) *	2013-10-12	2019-05-14	浙江华海药业股份有限公司	盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0818990A1 (en) *	1995-04-03	1998-01-21	Abbott Laboratories	Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) *	1997-11-21	1998-01-21	Smithkline Beecham Plc	Novel Formulation

1998
- 1998-05-13 GB GBGB9810180.1A patent/GB9810180D0/en not_active Ceased
1999
- 1999-05-13 EP EP99922303A patent/EP1077685A2/en not_active Withdrawn
- 1999-05-13 WO PCT/GB1999/001522 patent/WO1999058116A2/en not_active Ceased
- 1999-05-13 AP APAP/P/2000/001985A patent/AP2000001985A0/en unknown
- 1999-05-13 KR KR1020007012660A patent/KR20010043545A/ko not_active Withdrawn
- 1999-05-13 JP JP2000547967A patent/JP2002514593A/ja active Pending
- 1999-05-13 PL PL99344872A patent/PL344872A1/xx unknown
- 1999-05-13 IL IL13959699A patent/IL139596A0/xx unknown
- 1999-05-13 CN CN99808548A patent/CN1309557A/zh active Pending
- 1999-05-13 CA CA002331849A patent/CA2331849A1/en not_active Abandoned
- 1999-05-13 EA EA200001173A patent/EA200001173A1/ru unknown
- 1999-05-13 BR BR9910402-4A patent/BR9910402A/pt not_active Application Discontinuation
- 1999-05-13 TR TR2000/03351T patent/TR200003351T2/xx unknown
- 1999-05-13 ID IDW20002329A patent/ID27018A/id unknown
- 1999-05-13 HU HU0101931A patent/HUP0101931A3/hu unknown
- 1999-05-13 SK SK1697-2000A patent/SK16972000A3/sk unknown
- 1999-05-13 AU AU39410/99A patent/AU3941099A/en not_active Abandoned
2000
- 2000-11-09 ZA ZA200006465A patent/ZA200006465B/en unknown
- 2000-11-10 NO NO20005681A patent/NO20005681L/no not_active Application Discontinuation
- 2000-11-30 BG BG105011A patent/BG105011A/xx unknown

Also Published As

Publication number	Publication date
HUP0101931A2 (hu)	2002-04-29
ID27018A (id)	2001-02-22
JP2002514593A (ja)	2002-05-21
GB9810180D0 (en)	1998-07-08
TR200003351T2 (tr)	2001-03-21
EP1077685A2 (en)	2001-02-28
AP2000001985A0 (en)	2000-12-31
WO1999058116A3 (en)	2000-02-17
BR9910402A (pt)	2001-01-09
HUP0101931A3 (en)	2002-10-28
NO20005681L (no)	2000-12-01
CN1309557A (zh)	2001-08-22
CA2331849A1 (en)	1999-11-18
ZA200006465B (en)	2001-11-09
IL139596A0 (en)	2002-02-10
WO1999058116A2 (en)	1999-11-18
EA200001173A1 (ru)	2001-04-23
NO20005681D0 (no)	2000-11-10
AU3941099A (en)	1999-11-29
PL344872A1 (en)	2001-11-19
SK16972000A3 (sk)	2001-06-11
KR20010043545A (ko)	2001-05-25

Similar Documents

Publication	Publication Date	Title
EP0609777A3 (en)	1996-05-15	Detergent composition with improved soil removal ability, process for its production and use of a suitable polycarboxylate therefor.
MX9804588A (es)	1998-09-30	Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
WO2002032871A3 (en)	2003-02-06	Compounds and methods for treating multidrug resistance
BG105197A (en)	2001-10-31	Polymorph form of a medicament
YU12000A (sh)	2002-11-15	Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
BG105011A (en)	2001-07-31	Composition containing paroxetine
WO2000055287A3 (en)	2001-01-25	Perfumed detergent tablet
WO2000046210A3 (en)	2000-12-14	New process for preparing pesticidal intermediates
ZA99477B (en)	1999-09-23	Process for the preparation of (-)CIS-3-Hydroxy-1-Methyl-4-(2,4,6-Trimethoxyphenyl)Piperidine.
WO1999037291A3 (de)	1999-09-10	Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe
PL352104A1 (en)	2003-07-28	Oral composition containing perlite
HUP0202379A3 (en)	2003-04-28	New compounds, process for producing them and pharmaceutical compositions containing them
BG105010A (en)	2001-07-31	Medicamentous form containing paroxetine
BG103650A (en)	2000-06-30	Method for the preparation of eprosartan
AU9437698A (en)	1999-03-22	Compressed chloramine-t tablets and method for the production thereof
GB9920959D0 (en)	1999-11-10	Novel process
PL356523A1 (en)	2004-06-28	Substituted 1 and 2 naphthol mannich bases
AU7773900A (en)	2001-04-10	Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
IL137364A0 (en)	2001-07-24	A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
CA2331758A1 (en)	1999-11-18	Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
AU2002223617A1 (en)	2002-04-29	Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
YU71400A (sh)	2003-04-30	Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
HUP0203655A3 (en)	2004-07-28	Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds
WO1999040078A3 (en)	1999-10-07	Process for the preparation of sotolon
IL143051A0 (en)	2002-04-21	1,4-diaryl-2-fluoro-1-buten- 3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2- fluoro-2-butene compounds